XML 122 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Accounts Payable and Accrued Expenses (Tables)
12 Months Ended
Dec. 31, 2024
Accounts Payable and Accrued Expenses  
Schedule of Accounts Payable and Accrued Expenses

December 31,

($ in thousands)

2024

    

2023

Accounts payable

$

7,464

$

6,322

Accrued research and development

330

4,118

Accrued compensation

93

2,838

Other (1)

1,599

739

Total accounts payable and accrued expenses

$

9,486

$

14,017

(1) Other includes approximately $1.3 million of accrued consideration for the uBriGene Asset Purchase Agreement, see Note 5.